Research Analysts’ Weekly Ratings Updates for Waystar (WAY)

Several analysts have recently updated their ratings and price targets for Waystar (NASDAQ: WAY):

• 3/12/2026 – Waystar had its price target lowered by Deutsche Bank Aktiengesellschaft from $42.00 to $37.00. They now have a “buy” rating on the stock.
• 3/10/2026 – Waystar was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
• 3/5/2026 – Waystar had its “strong-buy” rating reaffirmed by Raymond James Financial, Inc.. They now have a $35.00 price target on the stock.
• 2/21/2026 – Waystar was downgraded by Wall Street Zen from “buy” to “hold”.
• 2/19/2026 – Waystar had its price target lowered by Wells Fargo & Company from $41.00 to $36.00. They now have an “overweight” rating on the stock.
• 2/18/2026 – Waystar had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $41.00 price target on the stock.
• 2/18/2026 – Waystar had its price target lowered by BMO Capital Markets from $47.00 to $30.00. They now have an “outperform” rating on the stock.
• 2/18/2026 – Waystar was given a new $27.00 price target by Evercore Inc.
• 2/18/2026 – Waystar had its “buy” rating reaffirmed by TD Cowen.
• 2/18/2026 – Waystar was given a new $33.00 price target by Loop Capital.
• 2/18/2026 – Waystar had its price target lowered by Canaccord Genuity Group Inc. from $54.00 to $30.00. They now have a “buy” rating on the stock.
• 2/18/2026 – Waystar had its price target lowered by The Goldman Sachs Group, Inc. from $44.00 to $38.00. They now have a “buy” rating on the stock.
• 2/18/2026 – Waystar had its price target lowered by Barclays PLC from $42.00 to $36.00. They now have an “overweight” rating on the stock.
• 2/18/2026 – Waystar was upgraded by Freedom Capital from “hold” to “strong-buy”.
• 2/18/2026 – Waystar had its price target lowered by Citigroup Inc. from $46.00 to $35.00. They now have a “buy” rating on the stock.
• 2/18/2026 – Waystar had its price target lowered by Truist Financial Corporation from $51.00 to $38.00. They now have a “buy” rating on the stock.
• 2/17/2026 – Waystar had its price target lowered by Needham & Company LLC from $46.00 to $33.00. They now have a “buy” rating on the stock.
• 2/7/2026 – Waystar was upgraded by Wall Street Zen from “hold” to “buy”.
• 2/4/2026 – Waystar was given a new $42.00 price target by Mizuho.
• 2/2/2026 – Waystar is now covered by Leerink Partners. They set an “outperform” rating and a $43.00 price target on the stock.
• 1/21/2026 – Waystar had its “hold (c)” rating reaffirmed by Weiss Ratings.
• 1/14/2026 – Waystar was given a new $44.00 price target by The Goldman Sachs Group, Inc..

Insider Activity

In other Waystar news, insider Eric L. (Ric) Sinclair III sold 40,225 shares of the company’s stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $30.08, for a total value of $1,209,968.00. Following the transaction, the insider directly owned 474,826 shares of the company’s stock, valued at $14,282,766.08. This represents a 7.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 4.10% of the stock is currently owned by insiders.

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.